The estimated Net Worth of Maggie Yuen is at least 4.03 百万$ dollars as of 15 August 2024. Ms. Yuen owns over 3,500 units of Penumbra Inc stock worth over 1,814,721$ and over the last 5 years she sold PEN stock worth over 287,129$. In addition, she makes 1,932,590$ as Chief Financial Officer at Penumbra Inc.
Sign up
Ms. Yuen PEN stock SEC Form 4 insiders trading
Maggie has made over 2 trades of the Penumbra Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently she sold 3,500 units of PEN stock worth 84,245$ on 15 August 2024.
The largest trade she's ever made was selling 4,313 units of Penumbra Inc stock on 26 May 2023 worth over 202,884$. On average, Maggie trades about 521 units every 30 days since 2019. As of 15 August 2024 she still owns at least 8,970 units of Penumbra Inc stock.
You can see the complete history of Ms. Yuen stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Maggie Yuen biography
Maggie S. Yuen serves as Chief Financial Officer of the Company. Yuen spent more than 20 years driving scalable finance organizations, processes and infrastructure in the Manufacturing, Medical Devices, and Life Science industries. She served as Vice President of Finance of the Genetic Science Division within Thermo Fisher Scientific, Inc. (NYSE: TMO) (Thermo Fisher), a business focused on instrument platforms, cloud-based software, content and services, from 2016 to 2019. In her role, Ms. Yuen directed finance operations, strategic planning and business development activities, among a number of other executive functions. Prior to Thermo Fisher, Ms. Yuen held leadership positions with increasing responsibility at Mirion Technologies (from 2012 to 2016), and senior finance roles at Boston Scientific (NYSE: BSX) (from 2007 to 2010), Glu Mobile (Nasdaq: GLUU) (from 2004 to 2007), and Johnson & Johnson (NYSE: JNJ) (from 2001 to 2004).
What is the salary of Maggie Yuen?
As the Chief Financial Officer of Penumbra Inc, the total compensation of Maggie Yuen at Penumbra Inc is 1,932,590$. There are 1 executives at Penumbra Inc getting paid more, with Johanna Roberts having the highest compensation of 2,556,370$.
How old is Maggie Yuen?
Maggie Yuen is 48, she's been the Chief Financial Officer of Penumbra Inc since 2019. There are 13 older and 3 younger executives at Penumbra Inc. The oldest executive at Penumbra Inc is Don Kassing, 78, who is the Presiding Independent Director.
What's Maggie Yuen's mailing address?
Maggie's mailing address filed with the SEC is 7555, Innovation Way, Innovation Business Center, Mason, Warren County, Ohio, 45040, United States.
Insiders trading at Penumbra Inc
Over the last 9 years, insiders at Penumbra Inc have traded over 197,637,326$ worth of Penumbra Inc stock and bought 700 units worth 109,480$ . The most active insiders traders include Adam Elsesser、Arani Bose、James Robert Pray. On average, Penumbra Inc executives and independent directors trade stock every 9 days with the average trade being worth of 2,030,383$. The most recent stock trade was executed by Harpreet Grewal on 4 September 2024, trading 782 units of PEN stock currently worth 159,614$.
What does Penumbra Inc do?
penumbra is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with significant unmet clinical needs. we design our therapies to provide our specialist physician customers with improved clinical outcomes through faster and safer procedures at significant overall cost savings to the healthcare system. today we have over 1,000 employees with sales operations in north america, europe, australia and asia.
What does Penumbra Inc's logo look like?
Complete history of Ms. Yuen stock trades at Atricure Inc、Penumbra Inc
Penumbra Inc executives and stock owners
Penumbra Inc executives and other stock owners filed with the SEC include:
-
Johanna Roberts,
Executive Vice President, General Counsel, Secretary -
Maggie Yuen,
Chief Financial Officer -
Adam Elsesser,
Chairman of the Board, Chief Executive Officer -
Lynn Rothman,
Executive Vice President, Chief Business Officer -
Maggie S. Yuen,
Chief Financial Officer -
James Pray,
President, International -
Arani Bose,
Chief Innovator, Director -
Johanna Roberts,
Exec. VP, Gen. Counsel & Sec. -
Lambert Shiu,
Chief Accounting Officer -
Janet Leeds,
Independent Director -
Surbhi Sarna,
Independent Director -
Adam Elsesser,
Co-Founder, Chairman, Pres & CEO -
Harpreet Grewal,
Independent Director -
Bridget O'Rourke,
Independent Director -
Thomas Wilder,
Independent Director -
Don Kassing,
Presiding Independent Director -
Lambert Shiu,
Chief Accounting Officer -
Gita Barry,
Exec. VP & GM of Immersive Healthcare -
Ben Tompkins,
Exec. VP of Devel. -
Shruthi Narayan,
Director of Marketing - Vascular -
Dr. Arani Bose M.D.,
Co-Founder & Director -
Jee Hamlyn-Harris,
Investor Relations Officer -
Corey L. Teigen M.D.,
Chief Scientific Officer -
Ben Sorci,
Exec. VP of Operations -
Kevin James Sullivan,
Director -
Robert D. Evans,
EVP, Gen. Counsel & Secretary -
Daniel Donen Davis,
President, North America -
Sridhar Kosaraju,
President -
Walter Charles Wang,
Director